home1_b

TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.

partnering
events

BIO International Convention

June 6–9, 2016 | San Fransisco, CA

2nd International Conference and Exhibition on Antibodies

July 11–12, 2016 | Philadelphia, PA